Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

RxSight, Inc.

RXST · Nasdaq · CIK 0001111485 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

18 Form 4 transaction lines observed in the same window
4 sales · 14 option, withholding, award, gift or other lines

Last qualifying purchase2025-01-16 · Corley Jesse Anderson · $55.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Weinberg EricSee remarks
○▼○
Kurtz Ronald M MDChief Medical Officer
○▼
Wilterding MarkChief Financial Officer
○▼
Goldshleger IlyaChief Operating Officer
○▼
Warner Robert KeithDirector
○
PALMISANO ROBERT JDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-01-16 · Corley Jesse Anderson.

Recent Form 4 activity

0Purchases
4Sales
19Other Form 4 lines
17SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER14 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
4,087,921
Previous report
3,975,689
Avg daily volume
882,847
Days to cover
4.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-01-16Corley Jesse AndersonPurchase (P)Common Stock1,767USD 31.13USD 55,007SEC filing ↗
2025-01-15Corley Jesse AndersonPurchase (P)Common Stock1,443USD 31.19USD 45,007SEC filing ↗
2024-11-13Corley Jesse AndersonPurchase (P)Common Stock11,365USD 44.92USD 510,491SEC filing ↗
2024-11-12Corley Jesse AndersonPurchase (P)Common Stock11,111USD 45.37USD 504,106SEC filing ↗
2024-05-17Tammenoms Bakker JulietPurchase (P)Common Stock5,000USD 61.09USD 305,450SEC filing ↗
2024-02-14Tammenoms Bakker JulietPurchase (P)Common Stock4,000USD 51.29USD 205,160SEC filing ↗
2024-02-12Tammenoms Bakker JulietPurchase (P)Common Stock4,000USD 50.38USD 201,520SEC filing ↗
2023-02-10Tammenoms Bakker JulietPurchase (P)Common Stock480,000USD 12.50USD 6,000,000SEC filing ↗
2021-11-17Corley Jesse AndersonPurchase (P)Common Stock8,150USD 12.49USD 101,794SEC filing ↗
2021-08-05Weinberg EricPurchase (P)Common Stock9USD 14.90USD 134SEC filing ↗
2021-08-05Goldshleger IlyaPurchase (P)Common Stock2,372USD 14.03USD 33,273SEC filing ↗
2021-08-05Kurtz Ronald M MDPurchase (P)Common Stock3,638USD 13.85USD 50,386SEC filing ↗
2021-08-04Weinberg EricPurchase (P)Common Stock615USD 16.25USD 9,994SEC filing ↗
2021-08-03Weinberg EricPurchase (P)Common Stock1USD 17.03USD 17SEC filing ↗
2021-08-03Weinberg EricPurchase (P)Common Stock31,250USD 16.00USD 500,000SEC filing ↗

Form 4 evidence

23 transaction lines in the latest 365-day window; 324 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-15Weinberg EricOption exercise / conversion (M)Common Stock35,168USD 4.34USD 152,629SEC filing ↗
2026-09-02Wilterding MarkSale (S)Common Stock7,765USD 6.96USD 54,044SEC filing ↗
2026-09-02Weinberg EricSale (S)Common Stock2,041USD 6.96USD 14,205SEC filing ↗
Show recent Form 4 evidence (23 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-15Weinberg EricOption exercise / conversion (M)Common Stock35,168USD 4.34USD 152,629SEC filing ↗
2026-09-02Wilterding MarkSale (S)Common Stock7,765USD 6.96USD 54,044SEC filing ↗
2026-09-02Weinberg EricSale (S)Common Stock2,041USD 6.96USD 14,205SEC filing ↗
2026-09-02Kurtz Ronald M MDSale (S)Common Stock5,100USD 6.96USD 35,496SEC filing ↗
2026-09-02Goldshleger IlyaSale (S)Common Stock2,041USD 6.96USD 14,205SEC filing ↗
2026-08-31Wilterding MarkOption exercise / conversion (M)Common Stock20,441USD —USD —SEC filing ↗
2026-08-31Weinberg EricOption exercise / conversion (M)Common Stock5,370USD —USD —SEC filing ↗
2026-08-31Kurtz Ronald M MDOption exercise / conversion (M)Common Stock13,425USD —USD —SEC filing ↗
2026-08-31Goldshleger IlyaOption exercise / conversion (M)Common Stock5,370USD —USD —SEC filing ↗
2026-06-17Warner Robert KeithAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17Tammenoms Bakker JulietAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17PALMISANO ROBERT JAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17Maniar ShwetaAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17LINK WILLIAM J PHDAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17Fountain TamaraAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17Corley Jesse AndersonAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-06-17COHEN RAYMOND WAward / grant (A)Common Stock30,864USD —USD —SEC filing ↗
2026-06-17Andrews JulieAward / grant (A)Common Stock37,037USD —USD —SEC filing ↗
2026-04-17Goldshleger IlyaOption exercise / conversion (M)Common Stock12,489USD 4.13USD 51,580SEC filing ↗
2026-02-28Wilterding MarkOption exercise / conversion (M)Common Stock20,441USD —USD —SEC filing ↗
2026-02-28Wilterding MarkTax withholding (F)Common Stock8,068USD 7.61USD 61,397SEC filing ↗
2026-02-28Gaines ScottOption exercise / conversion (M)Common Stock6,261USD —USD —SEC filing ↗
2026-02-28Gaines ScottTax withholding (F)Common Stock2,580USD 7.61USD 19,634SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRXST
CIK0001111485
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3851 Ophthalmic Goods
ExchangeNasdaq

Data coverage

Local Form 4 history324 transaction lines from 2021-07-30 to 2026-09-15
28 P purchase lines · 129 S sale lines · 167 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.